Literature DB >> 32271871

Ensuring Access to Medications in the US During the COVID-19 Pandemic.

G Caleb Alexander1,2, Dima M Qato3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32271871     DOI： 10.1001/jama.2020.6016

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  16 in total

1.  Cross-national comparison of psychosocial well-being and diabetes outcomes in adults with type 1 diabetes during the COVID-19 pandemic in US, Brazil, and Iran.

Authors:  Samereh Abdoli; Monica S V M Silveira; Mehri Doosti-Irani; Paulo Fanti; Katherine Miller-Bains; Elizabeth João Pavin; Edimariz Buin Cardoso; Leila Rafiee Vardanjani; Kobra Noorian; Danielle Hessler
Journal:  Diabetol Metab Syndr       Date:  2021-06-11       Impact factor: 3.320

2.  Preventing a Post-Pandemic Double Burden of Disease in the COVID-19 Pandemic.

Authors:  Amy Hai Yan Chan; Rob Horne
Journal:  Glob Adv Health Med       Date:  2021-05-03

3.  Change in modifiable dementia risk factors during COVID-19 lockdown: The experience of over 50s in Tasmania, Australia.

Authors:  Larissa Bartlett; James J R Brady; Maree Farrow; Sarang Kim; Aidan Bindoff; Hannah Fair; James C Vickers; Duncan Sinclair
Journal:  Alzheimers Dement (N Y)       Date:  2021-05-13

4.  Management of Agitation During the COVID-19 Pandemic.

Authors:  Ambrose H Wong; Lynn P Roppolo; Bernard P Chang; Kimberly A Yonkers; Michael P Wilson; Seth Powsner; John S Rozel
Journal:  West J Emerg Med       Date:  2020-05-22

5.  Together we unite: the role of the Commonwealth in achieving universal health coverage through pharmaceutical care amidst the COVID-19 pandemic.

Authors:  Amy Hai Yan Chan; Victoria Rutter; Diane Ashiru-Oredope; Chloe Tuck; Zaheer-Ud-Din Babar
Journal:  J Pharm Policy Pract       Date:  2020-05-13

6.  Community Pharmacists' Contributions to Disease Management During the COVID-19 Pandemic.

Authors:  Mark A Strand; Jeffrey Bratberg; Heidi Eukel; Mark Hardy; Christopher Williams
Journal:  Prev Chronic Dis       Date:  2020-07-23       Impact factor: 2.830

7.  Reducing the dose of neuromuscular blocking agents with adjuncts: a systematic review and meta-analysis.

Authors:  Valentin Weber; Tom E F Abbott; Gareth L Ackland
Journal:  Br J Anaesth       Date:  2020-11-17       Impact factor: 9.166

Review 8.  COVID-19 and older people in Asia: Asian Working Group for Sarcopenia calls to actions.

Authors:  Wee-Shiong Lim; Chih-Kuang Liang; Prasert Assantachai; Tung W Auyeung; Lin Kang; Wei-Ju Lee; Jae-Young Lim; Ken Sugimoto; Masahiro Akishita; Shu-Lih Chia; Ming-Yueh Chou; Yew-Yoong Ding; Katsuya Iijima; Hak C Jang; Shuji Kawashima; Miji Kim; Taro Kojima; Masafumi Kuzuya; Jenny Lee; Sang Y Lee; Yunhwan Lee; Li-Ning Peng; Ninie Y Wang; Yin-Wei Wang; Chang W Won; Jean Woo; Liang-Kung Chen; Hidenori Arai
Journal:  Geriatr Gerontol Int       Date:  2020-06       Impact factor: 3.387

9.  Continuity of care and outpatient management for patients with and at high risk for cardiovascular disease during the COVID-19 pandemic: A scientific statement from the American Society for Preventive Cardiology.

Authors:  Amit Khera; Seth J Baum; Ty J Gluckman; Martha Gulati; Seth S Martin; Erin D Michos; Ann Marie Navar; Pam R Taub; Peter P Toth; Salim S Virani; Nathan D Wong; Michael D Shapiro
Journal:  Am J Prev Cardiol       Date:  2020-05-01

Review 10.  Mechanical-Ventilation Supply and Options for the COVID-19 Pandemic. Leveraging All Available Resources for a Limited Resource in a Crisis.

Authors:  Mohammad Dar; Lakshmana Swamy; Daniel Gavin; Arthur Theodore
Journal:  Ann Am Thorac Soc       Date:  2021-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.